Arab Drug Company (ADCI) posted 161% year-on-year (YoY) higher net profits after tax at EGP 106 million in the first half (H1) of fiscal year (FY) 2024/2025
Updated 2/2/2025 9:39:00 AM
Arab Drug Company’s (ADCI) net profits after tax jumped 121% year on year (YoY) in the fiscal year (FY) 2023/2024.
Updated 7/31/2024 11:13:00 AM
Arab Drug Company’s (ADCI) net profits after tax jumped 14.1% year on year (YoY) in the first nine months of the fiscal year (FY) 2023/2024.
Updated 5/30/2024 3:23:00 AM
Arab Drug Company’s (ADCI) net profits after tax jumped 123% year on year (YoY) in the first half (H1) of fiscal year (FY) 2023/2024.
Updated 1/30/2024 10:32:00 AM
Arab Drug Company (ADCI) reported a 1% year-on-year (YoY) slip in net profits after tax for the first quarter (Q1) of the fiscal year (FY) 2023/2024.
Updated 11/15/2023 1:46:00 AM
Arab Drug Company (ADCI) reported a 108% year-on-year (YoY) hike in net profit after tax for the fiscal year (FY) 2022/2023.
Updated 7/31/2023 10:47:00 AM
Arab Drug is an Egypt-based company engaged in the pharmaceutical sector. The company focuses on the manufacture, packaging, and distribution of pharmaceutical products as well as chemical solutions for human and veterinary use.
Updated 5/1/2023 10:34:00 AM